Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 1014 are a BUY (93.46%), 68 are a HOLD (6.27%), 3 are a SELL (0.28%).
Analyst Raghuram Selvaraju, carries an average stock price target met ratio of 31.61% that have a potential upside of 47.88% achieved within 175 days. Previously, Raghuram Selvaraju worked at HC WAINWRIGHT.
Raghuram Selvaraju’s has documented 2,012 price targets and ratings displayed on 118 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on COCP, Cocrystal Pharma at 20-Jun-2025.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $288 was fulfilled within 3 days with a profit of $128.16 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$7
$-5.54 (-44.18%)
$20
2 months 7 days ago
(17-Apr-2025)
8/12 (66.67%)
$-2.11 (-23.16%)
55
Buy
1 years 6 days ago
(18-Jun-2024)
10/37 (27.03%)
$101 (102.02%)
298
Sell
1 years 7 months 4 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.8 (-0.99%)
300
Hold
$20
$7.46 (59.49%)
$60
1 years 7 months 30 days ago
(25-Oct-2023)
3/22 (13.64%)
$5.72 (40.06%)
40
Hold
$25
$12.46 (99.36%)
$40
1 years 11 months 5 days ago
(19-Jul-2023)
2/5 (40%)
$3.4 (15.74%)
215
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?